Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683

Procurement and Logistics Service

This public procurement record has 2 releases in its history.

Award

28 Jul 2021 at 14:45

Award Notice
Tender

14 Apr 2021 at 16:55

Tender Notice
Summary of the contracting process

The procurement process involves the purchase of Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials by the Procurement and Logistics Service, covering the health sector in the UK. The procurement procedure is classified as an open tender, which allows a wide range of suppliers to participate. The tender is currently active and runs until the submission deadline on 18th May 2021. The framework agreement is anticipated to commence on 7th September 2021, lasting for an initial term of two years, with options for extension for up to 24 months.

This tender presents significant opportunities for businesses engaged in the production and distribution of medical equipment and pharmaceuticals, particularly small and medium-sized enterprises (SMEs) looking to expand their market presence. Companies that specialise in radiopharmaceuticals or related medical supplies would be well-suited to bid for this contract, as it covers multiple lots with varying financial values, collectively reaching over £11.6 million for the overall procurement.

How relevant is this notice?

Notice Information

Notice Title

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683

Notice Description

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

Lot Information

Lot 1: Ioflupane I-123

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a CentralPurchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 2: MIBG I-123 metaiodobenzylguanidine

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 3: Sodium Iodide I-123

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 4: Sodium Iodide Therapy Capsule I-131

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 5: Sodium Iodide Liquid I-131

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 6: Therapeutic MIBG I-131 metaiodobenzylguanidine

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 7: Gallium Citrate Ga-67

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 8: Generator Krypton Gas Kr-81

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 9: Generator Technetium Mo-99/Tc-99m

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 10: Samarium Sm-153

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 11: Selenium Homocholic Acid Taurine/Tauroselcholic Acid Se-75

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 12: Radium Dichloride Ra-223

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 13: Indium DTPA In-111 Diethylenetriamine Pentaacetate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 14: OCTREOSCAN 122MBQ IN111 OCTREOTIDE

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 15: DMSA Dimercaptosuccinic Acid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 16: DTPA Diethylenetriamine Pentaacetate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 17: Exametazime

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 18: HDP Hydroxymethylene Diphosphonate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 19: Human Albumin Nanocolloid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 20: MAA Macro Aggregated Albumin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 21: Mertiatide

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 22: Mebrofenin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 23: MIBI Sestamibi - Methoxyisobutylisonitrile

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 24: Sodium Pyrophosphate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 25: Tetrofosmin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 26: Tin Colloid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 27 - Tektrotyd

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 28 - Diphosphono-Propanedicarbosylic Acid DPD

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 29 - Sirspheres

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 30 - Lutathera

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 31- Yttrium Silicate Y-90

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 32 - Sterile Nitrogen Vials

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02a618
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/017942-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

33151400 - Radiotherapy supplies

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£11,607,952 £10M-£100M
Lots Value
£11,607,967 £10M-£100M
Awards Value
Not specified
Contracts Value
£6,323,226 £1M-£10M

Notice Dates

Publication Date
28 Jul 20215 years ago
Submission Deadline
18 May 2021Expired
Future Notice Date
Not specified
Award Date
28 Jul 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active, Unsuccessful
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Procurement and Logistics Service
Additional Buyers

Belfast Health and Social Care Trust

Western Health and Social Care Trust

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT47 6YZ
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0A Derry City and Strabane
Delivery Location
Not specified
Local Authority
Derry City and Strabane
Electoral Ward
Enagh
Westminster Constituency
Foyle

Supplier Information

Number of Suppliers
4
Supplier Names

Bayer plc

Curium Pharma UK Ltd

GE HEALTHCARE LIMITED

XIEL LTD

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...